How to Think Clearly

"Never argue with stupid people. They will drag you down to their level and then beat you with experience." –Mark Twain

If you want to fully understand and appreciate the work of Mike Stathis, from his market forecasts and securities analysis to his political and economic analyses, you will need to learn how to think clearly if you already lack this vital skill.

For many, this will be a cleansing process that could take quite a long time to complete depending on each individual.

The best way to begin clearing your mind is to move forward with this series of steps:

1. GET RID OF YOUR TV SET, AND ONLY USE STREAMING SERVICES SPARINGLY.

2. REFUSE TO USE YOUR PHONE TO TEXT.

3. DO NOT USE A "SMART (DUMB) PHONE" (or at least do not use your phone to browse the Internet unless absolutely necessary).

4. STAY AWAY FROM SOCIAL MEDIA (Facebook, Instagram, Whatsapp, Snap, Twitter, Tik Tok unless it is to spread links to this site). 

5. STAY OFF JEWTUBE.

6. AVOID ALL MEDIA (as much as possible).

The cleansing process will take time but you can hasten the process by being proactive in exercising your mind.

You should also be aware of a very common behavior exhibited by humans who have been exposed to the various aspects of modern society. This behavior occurs when an individual overestimates his abilities and knowledge, while underestimating his weaknesses and lack of understanding. This behavior has been coined the "Dunning-Kruger Effect" after two sociologists who described it in a research publication. See here.

Many people today think they are virtual experts on every topic they place importance on. The reason for this illusory behavior is because these individuals typically allow themselves to become brainwashed by various media outlets and bogus online sources. The more information these individuals obtain on these topics, the more qualified they feel they are to share their views with others without realizing the media is not a valid source with which to use for understanding something. The media always has bias and can never be relied on to represent the full truth. Furthermore, online sources are even more dangerous for misinformation, especially due to the fact that search algorithms have been designed to create confirmation bias. 

A perfect example of the Dunning-Kruger Effect can be seen with many individuals who listen to talk radio shows. These shows are often politically biased and consist of individuals who resemble used car salesmen more than intellectuals. These talking heads brainwash their audience with cherry-picked facts, misstatements, and lies regarding relevant issues such as healthcare, immigration, Social Security, Medicaid, economics, science, and so forth. They also select guests to interview based on the agendas they wish to fulfill with their advertisers rather than interviewing unbiased experts who might share different viewpoints than the host.

Once the audience has been indoctrinated by these propagandists, they feel qualified to discuss these topics on the same level as a real authority, without realizing that they obtained their understanding from individuals who are employed as professional liars and manipulators by the media. 

Another good example of the Dunning-Kruger Effect can be seen upon examination of political pundits, stock market and economic analysts on TV.  They talk a good game because they are professional speakers. But once you examine their track record, it is clear that these individuals are largely wrong. But they have developed confidence in speaking about these topics due to an inflated sense of expertise in topics for which they continuously demonstrate their incompetence.

One of the most insightful analogies created to explain how things are often not what you see was Plato's Allegory of the Cave, from Book 7 of the Republic.

We highly recommend that you study this masterpiece in great detail so that you are better able to use logic and reason.  From there, we recommend other classics from Greek philosophers. After all, ancient Greek philosophers like Plato and Socrates created critical thinking.   

If you can learn how to think like a philosopher, ideally one of the great ancient Greek philosophers, it is highly unlikely that you will ever be fooled by con artists like those who make ridiculous and unfounded claims in order to pump gold and silver, the typical get-rich-quick, or multi-level marketing (MLM) crowd.





STOP Being Taken

If you want to do well as an investor, you must first understand how various forces are seeking to deceive you. 

Most people understand that Wall Street is looking to take their money.

But do they really understand the means by which Wall Street achieves these objectives? 

Once you understand the various tricks and scams practiced by Wall Street you will be better able to avoid being taken. 

Perhaps an even greater threat to investors is the financial media.

The single most important thing investors must do if they aim to become successful is to stay clear of all media.

That includes social media and other online platforms with investment content such as YouTube and Facebook, which are one million times worse than the financial media.

The various resources found within this website address these two issues and much more. 

Remember, you can have access to the best investment research in the world. But without adequate judgment, you will not do well as an investor.

You must also understand how the Wall Street and financial media parasites operate in order to do well as an investor. 

It is important to understand how the Jewish mafia operates so that you can beat them at their own game.

The Jewish mafia runs both Wall Street and the media. This cabal also runs many other industries.

We devote a great deal of effort exposing the Jewish mafia in order to position investors with a higher success rate in achieving their investment goals.

Always remember the following quotes as they apply to the various charlatans positioned by the media as experts and business leaders.   

“Beware of false prophets, which come to you in sheep's clothing, but inwardly they are ravening wolves.” - King James Bible - Matthew 7:15

"It's easier to fool people than to convince them that they have been fooled." –Mark Twain

It's also very important to remember this FACT.  All Viewpoints Are Not Created Equal.

Just because something is published in print, online, or aired in broadcast media does not make it accurate. 

More often than not, the larger the audience, the more likely the content is either inaccurate or slanted. 

The next time you read something about economics or investments, you should ask the following question in order to determine the credibility of the source.

Is the source biased in any way?  

That is, does the source have any agendas which would provide some kind of benefit accounting for conclusions that were made? 

Most individuals who operate websites or blogs sell ads or merchandise of some kind. In particular, websites that sell precious metals are not credible sources of information because the views published on these sites are biased and cannot be relied upon.

The following question is one of the first things you should ask before trusting anyone who is positioned as an expert. 

Is the person truly credible?  

Most people associate credibility with name-recognition. But more often than not, name-recognition serves as a predictor of bias if not lack of credibility because the more a name is recognized, the more the individual has been plastered in the media. 

Most individuals who have been provided with media exposure are either naive or clueless. The media positions these types of individuals as “credible experts” in order to please its financial sponsors; those who buy advertisements. 

In the case of the financial genre, instead of name-recognition or media celebrity status, you must determine whether your source has relevant experience on Wall Street as opposed to being self-taught. But this is just a basic hurdle that in itself by no means ensures the source is competent or credible.

It's much more important to carefully examine the track record of your source in depth, looking for accuracy and specific forecasts rather than open-ended statements. You must also look for timing since a broken clock is always right once a day.  Finally, make sure they do not cherry-pick their best calls. Always examine their entire track record. 

Don't ever believe the claims made by the source or the host interviewing the source regarding their track record. 

Always verify their track record yourself. 

The above question requires only slight modification for use in determining the credibility of sources that discuss other topics, such as politics, healthcare, etc.

We have compiled the most extensive publication exposing hundreds of con men pertaining to the financial publishing and securities industry, although we also cover numerous con men in the media and other front groups since they are all associated in some way with each other.

There is perhaps no one else in the world capable of shedding the full light on these con men other than Mike Stathis.

Mike has been a professional in the financial industry for nearly three decades. 

Alhough he publishes numerous articles and videos addressing the dark side of the industry, the core collection can be found in our ENCYCLOPEDIA of Bozos, Hacks, Snake Oil Salesmen and Faux Heroes

Also, the Image Library contains nearly 8,000 images, most of which are annotated.


At AVA Investment Analytics, we don't pump gold, silver, or equities because we are not promoters or marketers.

We actually expose precious metals pumpers, while revealing their motives, means, and methods.

We do not sell advertisements.

We actually go to great lengths to expose the ad-based content scam that's so pervasive in the world today. 

We do not receive any compensation from our content, other than from our investment research, which is not located on this website. 

We provide individual investors, financial advisers, analysts and fund managers with world-class research and unique insight.







Media Lies

If you listen to the media, most likely at minimum it's going to cost you hundreds of thousands of dollars over the course of your life time.

The deceit, lies, and useless guidance from the financial media is certainly a large contributor of these losses.

But a good deal of lost wealth comes in the form of excessive consumerism which the media encourages and even imposes upon its audience.

You aren’t going to know that you’re being brainwashed, or that you have lost $1 million or $2 million over your life time due to the media.

But I can guarantee you that with rare exception this will become the reality for those who are naïve enough to waste time on media.

It gets worse.

By listening to the media you are likely to also suffer ill health effects through excessive consumption of prescription drugs, and/or as a result of watching ridiculous medical shows, all of which are supportive of the medical-industrial complex.

And if you seek out the so-called "alternative media" as a means by which to escape the toxic nature of the "mainstream" media, you might make the mistake of relying on con men like Kevin Trudeau, Alex Jones, Joe Rogan, and many others.

This could be a deadly decision. As bad as the so-called "mainstream" media is, the so-called "alternative media" is even worse.

There are countless con artists spread throughout the media who operate in the same manner. They pretend to be on your side as they "expose" the "evil" government and corporations.

Their aim is to scare you into buying their alternatives.  This addresses the nutritional supplements industry which has become a huge scam.  

 

Why Does the Media Air Liars and Con Men?

The goal of the media is NOT to serve its audience because the audience does NOT pay its bills.

The goal of the media is to please its sponsors, or the companies that spend huge dollars buying advertisements.

And in order for companies to justify these expenses, they need the media to represent their cause.

The media does this by airing idiots and con artists who mislead and confuse the audience.

By engaging in "journalistic fraud," the media steers its audience into the arms of its advertisers because the audience is now misled and confused.

The financial media sets up the audience so that they become needy after having lost large amounts of money listening to their "experts." Desperate for professional help, the audience contacts Wall Street brokerage firms, mutual funds, insurance companies, and precious metals dealers that are aired on financial networks. This is why these firms pay big money for adverting slots in the financial media.

We see the same thing on a more obvious note in the so-called "alternative media," which is really a remanufactured version of the "mainstream media." Do not be fooled. There is no such thing as the "alternative media."  It really all the same. 

In order to be considered "media" you must have content that has widespread channels of distribution. Thus, all "media" is widely distributed.

And the same powers that control the distribution of the so-called "mainstream media" also control distribution of the so-called "alternative media."

The claim that there is an "alternative media" is merely a sales pitch designed to capture the audience that has since given up on the "mainstream media."  

The tactic is a very common one used by con men.

The same tactic is used by Washington to convince naive voters that there are meaningful differences between the nation's two political parties.

In reality, both parties are essentially the same when it comes to issues that matter most (e.g. trade policy and healthcare) because all U.S. politicians are controlled by corporate America. Anyone who tells you anything different simply isn't thinking straight.

On this site, we expose the lies and the liars in the media.

We discuss and reveal the motives and track record of the media’s hand-selected charlatans with a focus on the financial media.  




 

Why Stathis Was Banned

To date, we know of no one who has established a more accurate track record in the investment markets since 2006 than Mike Stathis.  

Yet, the financial media wants nothing to do with Stathis.  

This has been the case from day one when he was black-balled by the publishing industry after having written his landmark 2006 book, America's Financial Apocalypse

From that point on, he was black-balled throughout all so-called mainstream media and then even the so-called alternative media. 

With very rare exception, you aren't even going to hear him on the radio or anywhere else being interviewed.  

Ask yourself why. 

You aren't going to see him mentioned on any websites either, unless its by people whom he has exposed.  

You aren't likely to ever read or hear of his remarkable investment research track record anywhere, unless you read about it on this website.

You should be wondering why this might be.

Some of you already know the answer.

The media banned Mike Stathis because the trick used by the media is to promote cons and clowns so that the audience will be steered into the hands of the media's financial sponsors - Wall Street, gold dealers, etc. 

Because the media is run by the Jewish mafia and because most Jews practice a severe form of tribalism, the media will only promote Jews and gentiles who represent Jewish businesses.  

And as for radio shows and websites that either don't know about Stathis or don't care to hear what he has to say, the fact is that they are so ignorant that they assume those who are plastered throughout media are credible.

And because they haven't heard Stathis anywhere in the media, even if they come across him, they automatically assume he's a nobody in the investment world simply because he has no media exposure.  And they are too lazy to go through his work because they realize they are too stupid to understand the accuracy and relevance of his research. 

Top investment professionals who know about Mike Stathis' track record have a much different view of him. But they cannot say so in public because Stathis is now considered a "controversial" figure due to his stance on the Jewish mafia. 

Most people are in it for themselves. Thus, they only care about pitching what’s deemed as the “hot” topic because this sells ads in terms of more site visits or reads.

This is why you come across so many websites based on doom and conspiratorial horse shit run by con artists.

We have donated countless hours and huge sums of money towards the pursuit of exposing the con men, lies, and fraud.

We have been banned by virtually every media platform in the U.S and every website prior to writing about the Jewish mafia.

Mike Stathis was banned by all media early on because he exposed the realities of the United States.

The Jewish mafia has declared war on us because we have exposed the realities of the U.S. government, Wall Street, corporate America, free trade, U.S. healthcare, and much more.

Stathis has also been banned by alternative media because he exposed the truth about gold and silver. 

We have even been banned from use of email marketing providers as a way to cripple our abilities to expand our reach. 

You can talk about the Italian Mafia, and Jewish Hollywood can make 100s of movies about it.

BUT YOU CANNOT TALK ABOUT THE JEWISH MAFIA.

Because Mr. Stathis exposed so much in his 2006 book America's Financial Apocalypse, he was banned.

He was banned for writing about the following topics in detail: political correctness, illegal immigration, affirmative action, as well as the economic realities behind America's disastrous healthcare system, the destructive impact of free trade, and many other topics. He also exposed Wall Street fraud and the mortgage derivatives scam that would end of catalyzing the worst global crisis in history. 

It's critical to note that the widespread ban on Mr. Stathis began well before he mentioned the Jewish mafia or even Jewish control of any kind.

It was in fact his ban that led him to realize precisely what was going on.

We only began discussing the role of the criminality of the Jewish mafia by late-2009, three years AFTER we had been black-listed by the media.

Therefore, no one can say that our criticism of the Jewish mafia led to Mike being black-listed (not that it would even be acceptable).  

If you dare to expose Jewish control or anything under Jewish control, you will be black-balled by all media so the masses will never hear the truth.

Just remember this. Mike does not have to do what he is doing. 

Instead, he could do what everyone else does and focus on making money. 

He has already sacrificed a huge fortune to speak the truth hoping to help people steer clear of fraudsters and to educate people as to the realities in order to prevent the complete enslavement of world citizenry. 

  

Rules to Remember

Rule #1: Those With Significant Exposure Are NOT on Your Side.  

No one who has significant exposure should ever be trusted. Such individuals should be assumed to be gatekeepers until proven otherwise.  I have never found an exception to this rule.

Understand that those responsible for permitting or even facilitating exposure have given exposure to specific individuals for a very good reason. And that reason does not serve your best interests. 

In short, I have significant empirical evidence to conclude that everyone who has a significant amount of exposure has been bought off (in some way) by those seeking to distort reality and control the masses. This is not a difficult concept to grasp. It's propaganda 101.   

Rule #2: Con Artists Like to Form Syndicates.

Before the Internet was created, con artists were largely on their own. Once the Internet was released to the civilian population, con artists realized that digital connectivity could amplify their reach, and thus the effectiveness of their mind control tactics. This meant digital connectivity could amplify the money con artists extract from their victims by forming alliances with other con artists.

Teaming up with con artists leads to a significantly greater volume of content and distraction, such that victims of these con artists are more likely to remain trapped within the web of deceit, as well as being more convinced that their favorite con artist is legit. 

Whenever you wish to know whether someone can be trusted, always remember this golden rule..."a man is judged by the company he keeps." This is a very important rule to remember because con men almost always belong to the same network.  You will see the same con artists interviewing each other,referencing each other, (e.g. a hat tip) on the same blog rolls, attending the same conferences, mentioning their con artist peers, and so forth.

Rule #3: There's NO Free Lunch.  

Whenever something is marketed as being "free" you can bet the item or service is either useless or else the ultimate price you'll pay will be much greater than if you had paid money for it in the beginning. 

You should always seek to establish a monetary relationship with all vendors because this establishes a financial link between you the customer and the vendor. Therefore, the vendor will tend to serve and protect your best interests because you pay his bills. 

Those who use the goods and services from vendors who offer their products for free will treated not as customers, but as products, because these vendors will exploit users who are obtaining  their products for free in order to generate income.   

Use of free emails, free social media, free content is all complete garbage designed to obtain your data and sell it to digital marketing firms.

From there you will be brainwashed with cleverly designed ads. You will be monitored and your identity wil eventually be stolen. 

Fraudsters often pitch the "free" line in order to lure greedy people who think they can get something for free. 

Perhaps now you understand why the system of globalized trade was named "free trade." 

As you might appreciate, free trade has been a complete disaster and scam designed to enrich the wealthy at the expense of the poor. 

There are too many examples of goods and services positioned as being free, when in reality, the customers get screwed.  

Rule #4: Beware of Manipulation Using Word Games. 

When manipulators want to get the masses to side with their propaganda and ditch more legitimate alternatives they often select psychologically relevant labels to indicate positive or negative impressions.

For instance, the financial parasites running America's medical-industrial complex have designated the term "socialized medicine" to replace the original, more accurate term, "universal healthcare." This play on words has been done to sway the masses from so much as even investigating universal healthcare, because the criminals want to keep defrauding people with their so-called "market-based" healthcare scam, which has accounted for the number one cause of personal bankruptcies in the USA for many years.  

When Wall Street wanted to convince the American people to go along with NAFTA, they used the term "free trade" to describe the current system of trade which has devastated the U.S. labor force.

In reality, free trade is unfair trade and only benefits the wealthy and large corporations.

There are many examples on this play on words such as the "sharing economy" and so on.  

Rule #5: Whenever Someone Promotes Something that Offers to Empower You, It's Usually a Scam.

This applies to the life coaches, self-help nonsense, libertarian pitches, FIRE movement, and so on.

If it sounds too good to be true, it usually is.

Unlike what the corporate fascists claim, we DO need government.

And no, you can NOT become financially independent and retire early unless you sell this con game to suckers.  

Rule #6: "Never argue with stupid people. They will drag you down to their level and then beat you with experience." –Mark Twain

Following this rule is forcing the small and dewindling group of intelligent people left in the world to cease interacting with people. 

You might need to get accustomed to being alone if you're intelligent and would rather not waste your time arguing with someone who is so ignorant, that they have no chance to realize what's really going in this world. 

It would seem that Dunning-Kruger has engulfed much of the population, especially in the West.     

Start Here

Artificial Intelligence Assessment of Mike Stathis' Expertise in U.S. Healthcare

Today, we including an expanded analysis of Mike Stathis expertise in healthcare by including excerpts from his 2009 book, America's Healthcare Solution in addition to healthcare-related excerpts from his 2006 book America's Financial Apocalypse.

See the following URL for the previous assessment by Grok-3:

Artificial Intelligence Assessment of Mike Stathis' 2006 Analysis & Recommendations on U.S. Healthcare Show He's a Visionary Expert

REQUEST FOR GROK-3: Now conduct the same analysis after including the following excerpts (not displayed due to copyright) from Stathis' 2009 healthcare book, America's Healthcare Solution. This time create a table that compares Stathis’ analysis and insights with those of the leading healthcare experts.  

 

Key Points

Research suggests Stathis' predictions on telemedicine and healthcare IT growth were accurate, aligning with 2025 trends.

It seems likely that his concerns about high drug prices remain relevant, with recent efforts like Trump's May 2025 executive order showing mixed results.

The evidence leans toward his call for universal healthcare not being adopted, with U.S. focusing on reforms like telehealth expansion instead.

There is controversy around drug price controls, with experts debating their effectiveness and implementation challenges.

Stathis' Research Overview

Mike Stathis, in his 2006 book America's Financial Apocalypse and 2009 book America's Healthcare Solution, highlighted critical issues in U.S. healthcare, including high costs, inefficiencies, lack of universal coverage, and the need for telemedicine and healthcare IT. He criticized the pharmaceutical industry's monopoly and emphasized the chronic disease crisis, advocating for systemic changes.

Comparison with 2025 Developments

Drug Prices and Recent Efforts: Trump's executive order on May 12, 2025, aims to lower drug prices by aligning with international rates, potentially cutting costs by 30% to 80% Trump executive order demands pharma industry price cuts. However, outcomes are uncertain, and the Inflation Reduction Act has introduced measures like capping Medicare out-of-pocket costs at $2,000 annually, but drug prices remain a concern.

Advances in Telemedicine and Healthcare IT: Telemedicine has grown, with the market projected to reach $63.31 billion by 2030, driven by AI and remote monitoring U.S. Telehealth Market Size & Share | Industry Report, 2030. Healthcare IT, including AI, is transforming care delivery, aligning with Stathis' predictions.

Universal Healthcare and Access: There has been no move towards a national system, with reforms focusing on technology and workforce, not systemic overhaul.

Analysis of Mike Stathis' Research in the Context of 2025 U.S. Healthcare

This report provides a comprehensive analysis of Mike Stathis' research from his 2006 book America's Financial Apocalypse and his 2009 book America's Healthcare Solution, focusing on U.S. healthcare, and compares it with the current state in 2025, including recent developments like Trump's executive order to reduce drug prices and advances in healthcare IT and telemedicine. It also contrasts his work with the predictions and insights of leading healthcare experts for 2025, ensuring a thorough examination of all relevant details.

 

Background on Stathis' Research

Stathis' 2006 book addressed several pressing issues in the U.S. healthcare system, emphasizing the problematic link between employment and health insurance, noting that job losses due to outsourcing left millions without coverage.

He highlighted the high cost of healthcare, with the U.S. spending more per capita than any other nation yet achieving relatively low quality outcomes, ranked 17th globally among developed nations. Stathis criticized the profiteering by HMOs, insurance companies, and pharmaceutical firms, arguing that these entities prioritized profits over patient care, contributing to inefficiencies and waste.

He advocated for a national healthcare system, pointing out that the lack of universal coverage, unlike in Europe and Asia, undermined U.S. competitiveness and economic stability.

Additionally, he discussed the inadequacies of Medicare and Medicaid, predicting financial burdens from the baby boomer generation, and foresaw growth in telemedicine and healthcare IT as cost-effective solutions.

In his 2009 book, Stathis continued this critique, emphasizing the need for restructuring the healthcare system to address excessive costs, poor accessibility, massive waste, medical errors, and fraud.

He argued that the current system lacks true free market dynamics, instead being characterized by industry collusion and profiteering.

He positioned telemedicine and healthcare informatics as the foundation for America's healthcare solution, predicting they would improve efficiency, reduce costs, and enhance clinical outcomes.

Stathis highlighted the historical context, noting that healthcare was once more affordable and physician-driven, but had become industrialized and profit-centric, leading to high costs and low quality.

He specifically criticized the pharmaceutical industry's monopoly, high drug prices due to lack of controls, and the chronic disease crisis, advocating for cost controls and prevention-focused strategies.

 

Current U.S. Healthcare Landscape in 2025

As of May 13, 2025, several developments align with or diverge from Stathis' predictions:

Drug Prices: Recent efforts to address high drug costs include President Trump's executive order signed on May 12, 2025, aiming to lower prices by aligning them with international rates under a "Most Favored Nation" policy, with potential cuts of 30% to 80% Trump executive order demands pharma industry price cuts. This follows his earlier attempts, blocked by courts, and is part of broader discussions around the Inflation Reduction Act, which has introduced measures to reduce drug costs for Medicare beneficiaries, such as capping out-of-pocket expenses at $2,000 annually and allowing Medicare to negotiate prices for certain drugs.

Pharmacy dispensing revenue continues to grow, reaching $620 billion in 2023, with specialty pharmacy as a fast-growing segment, driven by rising costs of GLP-1 drugs and innovation for chronic conditions Medical cost trend: Behind the numbers 2025. However, the effectiveness and implementation of these policies remain uncertain, reflecting ongoing challenges with high drug prices.

Telemedicine and Healthcare IT: Stathis' prediction of telemedicine growth has materialized, with the market projected to reach $63.31 billion by 2030, driven by AI, 5G, and remote patient monitoring U.S. Telehealth Market Size & Share | Industry Report, 2030. Recent legislation extended Medicare telehealth flexibilities through September 30, 2025, allowing broader access, especially for non-behavioral/mental health care at home Telehealth policy updates | Telehealth.HHS.gov. Healthcare IT is advancing, with the U.S. digital health market expected to grow from $79.10 billion in 2024 to $248.11 billion by 2034, focusing on data analytics, AI, and telehealth to improve efficiency and patient outcomes U.S. Digital Health Market Size to Surpass USD 248.11 Billion by 2034. Experts highlight the role of digital health in addressing high costs and inefficiencies, with a focus on securing patient data amid growing cyber threats Future of Telemedicine: 8 Telemedicine Trends in 2025.

Universal Healthcare: Despite Stathis' advocacy, there has been no move towards a national healthcare system. Instead, the U.S. has focused on reforms like telehealth expansion and drug price controls, reflecting a preference for incremental changes rather than systemic overhaul.

Chronic Disease Management: Chronic diseases remain a major focus, with advancements in personalized treatments, AI-driven diagnostics, and preventive care strategies. The chronic disease crisis, as Stathis predicted, continues to drive healthcare costs, with expenditures expected to rise significantly due to an aging population How has U.S. spending on healthcare changed over time?.

Inefficiencies and Waste: Efforts to reduce administrative burdens through AI and digital tools are underway, but systemic inefficiencies persist, with administrative costs still high compared to other nations, as Stathis noted Health care transformation and growth: 2025 and beyond | EY - US.

 

Leading Healthcare Experts and Their Insights for 2025

The following experts from Mass General Brigham provided predictions for 2025, as reported by Fox News.

Bryan Choi, MD, PhD (Investigator, Department of Neurosurgery, Massachusetts General Hospital): Predicts continued breakthroughs in immunotherapy for cancer, FDA approvals for cell therapies for solid tumors, and use in autoimmune diseases.

Shawn Demehri, MD, PhD (Investigator, Mass General Cancer Center, Massachusetts General Hospital): Focuses on novel discoveries and strategies for early cancer detection and prevention, utilizing the immune system for prevention in high-risk populations.

Elizabeth Mittendorf, MD, PhD, MHCM (Investigator, Department of Surgery, Brigham and Women’s Hospital): Expects progress in identifying biomarkers to personalize breast cancer care, reducing immunotherapy toxicities.

Raul Mostoslavsky, PhD (Investigator, Krantz Family Center for Cancer Research, Massachusetts General Hospital): Anticipates major breakthroughs in spatial transcriptomics and sub-cellular imaging for embryo development and cancer progression.

Shuji Ogino, MD, PhD, MS (Chief of Molecular Pathological Epidemiology Program, Department of Pathology, Brigham and Women’s Hospital): Emphasizes the long-term impact of multiple environmental factors on cancer development processes.

E. Antonio Chiocca, MD, PhD, FAANS (Executive Director, Center for Tumors of the Nervous System, Mass General Brigham): Predicts an uptick in AI usage to support physicians, streamline workflows, and expand robotics/AI in brain/spine surgeries.

Michael Fox, MD, PhD (Director, Center for Brain Circuit Therapeutics, Brigham and Women’s Hospital): Sees advances in non-invasive brain stimulation for faster, personalized, and at-home treatment of brain diseases.

Alexandra Golby, MD (Investigator, Neurosciences Center, Brigham and Women’s Hospital): Expects breakthroughs in focused ultrasound for non-invasive blood-brain barrier opening, enabling treatments for brain disorders.

Andreas Horn, MD, PhD (Director, Center for Brain Circuit Therapeutics, Brigham and Women’s Hospital): Predicts transcranial magnetic stimulation for depression treatable in days, with high remission rates using pharmacological co-agents.

Jonathan Rosand, MD, MSc (JP Kistler Endowed Chair in Neurology, Co-Founder, McCance Center for Brain Health, Massachusetts General Hospital): Focuses on preventing dementia, stroke, and depression as a cornerstone of primary care, using the Brain Care Score (BCS) to reduce risk by up to 50%.

Ipsit V. Vahia, MD (Investigator, Division of Geriatric Psychiatry, McLean Hospital): Predicts advances in dementia care, including AI for early diagnosis, personalized treatments, and GUIDE Model implementation.

Michael Honigberg, MD, MPP (Investigator, Cardiology Division, Massachusetts General Hospital): Expects completion of the first large outcomes-focused clinical trial for lipoprotein(a) targeting medications.

Edy Kim, MD, PhD (Investigator, Pulmonary Division, Brigham and Women’s Hospital): Sees discovery of molecular biomarkers for proactive cardiac critical care, identifying at-risk patients for early interventions.

Emily S. Lau, MD, MPH (Investigator, Cardiometabolic Health and Hormones Clinic, Massachusetts General Hospital): Predicts significant advancements in women's health research, improving quality of life and cardiovascular health in mid-life/menopausal women.

Mandeep R. Mehra, MBBS, MSc (Executive Director, Center for Advanced Heart Disease, Brigham and Women’s Hospital): Expects AI-facilitated algorithms for early detection and genetically informed treatments to reduce cardiovascular disease risk.

Pradeep Natarajan, MD, MMSc (Director, Preventive Cardiology, Massachusetts General Hospital): Highlights increased focus on cardio-kidney-metabolic health, necessitating new interdisciplinary care models.

Caroline Apovian, MD (Co-Director, Center for Weight Management and Wellness, Brigham and Women’s Hospital): Focuses on uncovering answers about nutrient metabolism and why a calorie is not a calorie, improving understanding of weight gain.

William Hwang, MD, PhD (Investigator, Center for Systems Biology, Krantz Family Center for Cancer Research, Department of Radiation Oncology, Massachusetts General Hospital): Predicts AI integration to supplement physician knowledge, improve data interpretation, and reduce administrative burden.

Shaan Khurshid, MD, MPH (Investigator, Telemachus and Irene Demoulas Family Foundation Center for Cardiac Arrhythmias, Massachusetts General Hospital): Expects implementation of generative AI language models (chatbots) for routine clinical care like patient communications and diagnostic reports.

David Levine, MD, MPH, MA (Clinical Director of Research and Development, Mass General Brigham): Predicts use of drones to transform healthcare delivery, making home the center of care for primary, urgent, emergency, and public health.

Calum A. MacRae, MD, PhD (Vice Chair for Scientific Innovation, Brigham and Women’s Hospital): Sees increased access to personalized data driving self-care in preventative medicine, impacting chronic disease management.

Susan A. Slaugenhaupt, PhD (Scientific Director, Mass General Research Institute, Massachusetts General Hospital): Expects many more patients benefiting from genetic therapies, with nearly 40 gene/cell therapies approved and hundreds expected.

These experts collectively emphasize technological advancements (AI, drones, genetic therapies) and focus on chronic disease management (cancer, dementia, cardiovascular diseases), aligning with some of Stathis' concerns but not addressing systemic issues like universal coverage or drug price controls directly.

 

Detailed Comparison and Analysis

To organize the comparison, the following table summarizes the key aspects:

Aspect

Stathis' Research (2006/2009)

Current Developments (2025)

2025 Experts' Insights

High Healthcare Costs

Criticized U.S. for high costs and poor outcomes; advocated for systemic changes like price controls.

Trump's executive order aims to lower drug prices; Inflation Reduction Act introduces measures, but costs remain high.

Focus on technological solutions (AI, drones) to improve efficiency; no direct address of systemic cost issues.

Lack of Universal Coverage

Advocated for a national healthcare system to ensure access.

No move towards universal healthcare; focus on reforms like telehealth expansion.

No direct mention; focus on improving access through technology (e.g., drones, AI).

Inefficiencies and Waste

Highlighted high administrative costs, fraud, and overuse of services.

Efforts to reduce administrative burdens through AI and digital tools, but inefficiencies persist.

Predictions include AI to reduce administrative burden (Hwang, Khurshid) and streamline care.

Drug Industry Monopoly

Criticized high drug prices due to lack of controls and industry collusion.

Recent policies aim to address drug prices, but effectiveness is uncertain.

No direct mention; focus on new therapies and approvals, not pricing.

Telemedicine and Healthcare IT

Predicted growth as cost-effective solutions for access and efficiency.

Significant market growth; integration of AI and digital health solutions.

Strong emphasis on AI (Chiocca, Hwang, Khurshid), drones (Levine), and digital health for better care delivery.

Chronic Disease Crisis

Emphasized need for better management strategies; chronic diseases drive costs.

Advancements in personalized treatments, AI-driven diagnostics, and preventive care.

Multiple predictions on advancements in treating chronic diseases (e.g., cancer, dementia, cardiovascular diseases).

 

Stathis' foresight on telemedicine and healthcare IT is validated by 2025 trends, with significant market growth and technological integration. His concerns about chronic disease management are also still relevant, with ongoing research and advancements in this area. However, his advocacy for systemic changes like universal healthcare and drug price controls is not reflected in the experts' predictions, possibly because these are more political issues than medical or technological ones. The experts are focusing on what they can influence directly through research and innovation, rather than policy changes.

Recent developments, such as Trump's executive order on drug prices and the Inflation Reduction Act, show some progress toward addressing high drug costs, but their long-term impact remains uncertain.

Telemedicine and healthcare IT have indeed grown as Stathis predicted, with AI and digital solutions playing a significant role in improving efficiency and access. However, the lack of progress toward universal healthcare highlights the political challenges of implementing systemic reforms.

 

Conclusion

Mike Stathis' research was prescient in identifying the transformative potential of telemedicine and healthcare IT, which have become central to modern healthcare delivery in 2025. His concerns about chronic disease management also remain highly relevant, as evidenced by the experts' focus on advancements in this area.

However, his calls for systemic change, such as universal healthcare and drug price controls, have not yet been realized. The 2025 experts are optimistic about innovation but operate within the constraints of the current healthcare framework, focusing on what can be achieved through research and technology rather than advocating for fundamental policy shifts.

Key Citations

 

REQUEST FOR GROK-3: Add to this analysis by integrating more excerpts from Stathis' 2009 book (not displayed due to copyright). In addition, please expand on your analysis of healthcare experts by including the following: Marty Makary, Uwe Reinhardt, Elizabeth Rosenthal, and Atul Gawande. After you have discussed the analysis and made comparisons of each expert (including those you previously listed) make a table with each expert along with Stathis to compare contributions, insights and predictions.

 

Key Points

Research suggests Stathis' predictions on telemedicine and healthcare IT growth were accurate, aligning with 2025 trends.

It seems likely that his concerns about high drug prices remain relevant, with recent efforts showing mixed results.

The evidence leans toward his call for universal healthcare not being adopted, with U.S. focusing on reforms instead.

There is controversy around drug price controls, with experts debating their effectiveness.

Drug Prices and Recent Efforts

Mike Stathis highlighted high drug prices as a major issue due to lack of controls. In 2025, President Trump's executive order on May 12 aims to lower prices by aligning with international rates, potentially cutting costs by 30% to 80% Trump executive order demands pharma industry price cuts. However, pharmaceutical companies are planning to raise prices on over 250 drugs starting in January 2025, with increases generally below 10%, indicating ongoing challenges Pharma to raise prices on more than 250 drugs in the US from January 2025.

Advances in Telemedicine and Healthcare IT

Stathis predicted telemedicine and healthcare IT would grow, and by 2025, it's booming, with the market projected to reach $63.31 billion by 2030, driven by AI and remote monitoring U.S. Telehealth Market Size & Share | Industry Report, 2030. Recent policies extend Medicare telehealth flexibilities through September 2025, enhancing access.

Universal Healthcare

Despite Stathis' advocacy, the U.S. in 2025 still lacks universal healthcare, relying on private insurance and government programs, with debates continuing about its benefits Healthcare in the United States.

Expert Comparisons

Experts like Marty Makary, Uwe Reinhardt, Elizabeth Rosenthal, and Atul Gawande echo Stathis' concerns, focusing on transparency, costs, and delivery systems, but their approaches vary, with some emphasizing technology and others patient advocacy.

 

Analysis of Mike Stathis' Research in Context of 2025 U.S. Healthcare

This report provides a comprehensive analysis of Mike Stathis' research from his 2006 book America's Financial Apocalypse and his 2009 book America's Healthcare Solution, focusing on U.S. healthcare, and compares it with the current state in 2025, including recent developments like Trump's executive order to reduce drug prices and advances in healthcare IT and telemedicine. It also contrasts his work with the predictions and insights of leading healthcare experts: Marty Makary, Uwe Reinhardt, Elizabeth Rosenthal, and Atul Gawande, ensuring a thorough examination of all relevant details.

 

Background on Stathis' Research

Stathis' 2006 book addressed several pressing issues in the U.S. healthcare system, emphasizing the problematic link between employment and health insurance, noting that job losses due to outsourcing, particularly under free trade agreements, left millions without coverage. He highlighted the high cost of healthcare, with the U.S. spending more per capita than any other nation yet achieving relatively low quality outcomes, ranked 17th globally among developed nations.

Stathis criticized the profiteering by HMOs, insurance companies, and pharmaceutical firms, arguing that these entities prioritized profits over patient care, contributing to inefficiencies and waste. He advocated for a national healthcare system, pointing out that the lack of universal coverage, unlike in Europe and Asia, undermined U.S. competitiveness and economic stability.

Additionally, he discussed the inadequacies of Medicare and Medicaid, predicting financial burdens from the baby boomer generation, and foresaw growth in telemedicine and healthcare IT as cost-effective solutions.

In his 2009 book, Stathis continued this critique, emphasizing the need for restructuring the healthcare system to address excessive costs, poor accessibility, massive waste, medical errors, and fraud.

He argued that the current system lacks true free market dynamics, instead being characterized by industry collusion and profiteering.

He positioned telemedicine and healthcare informatics as the foundation for America's healthcare solution, predicting they would improve efficiency, reduce costs, and enhance clinical outcomes.

Stathis highlighted the historical context, noting that healthcare was once more affordable and physician-driven, but had become industrialized and profit-centric, leading to high costs and low quality. He specifically criticized the pharmaceutical industry's monopoly, high drug prices due to lack of controls, and the chronic disease crisis, advocating for cost controls and prevention-focused strategies.

From the additional excerpts, Stathis emphasized the healthcare-employment link, noting globalization and free trade policies like NAFTA have eroded job security and healthcare access for 160 million Americans relying on employer-sponsored plans.

He highlighted the economic consequences, such as wage squeezes and outsourcing, and predicted a healthcare bubble due to unsustainable costs, with potential job losses and reduced coverage.

Stathis also discussed the chronic disease crisis, noting its cost implications with baby boomers aging, and proposed telemedicine as a solution for integrated disease management and prevention.

He criticized Medicare Part D for subsidizing drug industry profits and called for price controls and increased competition to address systemic issues.

 

Current U.S. Healthcare Landscape in 2025

As of 09:19 PM PDT on Tuesday, May 13, 2025, several developments align with or diverge from Stathis' predictions:

Drug Prices: Recent efforts to address high drug costs include President Trump's executive order signed on May 12, 2025, aiming to lower prices by aligning them with international rates under a "Most Favored Nation" policy, with potential cuts of 30% to 80% Trump executive order demands pharma industry price cuts. This follows his earlier attempts, blocked by courts, and is part of broader discussions around the Inflation Reduction Act, which has introduced measures to reduce drug costs for Medicare beneficiaries, such as capping out-of-pocket expenses at $2,000 annually and allowing Medicare to negotiate prices for certain drugs What are the recent and forecasted trends in prescription drug spending? - Peterson-KFF Health System Tracker. However, pharmaceutical companies are planning to raise prices on over 250 drugs starting in January 2025, with increases generally below 10%, indicating ongoing challenges Pharma to raise prices on more than 250 drugs in the US from January 2025.

Telemedicine and Healthcare IT: Stathis' prediction of telemedicine growth has materialized, with the market projected to reach $63.31 billion by 2030, driven by AI, 5G, and remote patient monitoring U.S. Telehealth Market Size & Share | Industry Report, 2030. Recent legislation extended Medicare telehealth flexibilities through September 30, 2025, allowing broader access, especially for non-behavioral/mental health care at home Telehealth policy updates | Telehealth.HHS.gov. The DEA and HHS have also extended telemedicine flexibilities for prescribing controlled medications through December 31, 2025 DEA and HHS Extend Telemedicine Flexibilities through 2025. Healthcare IT is advancing, with the U.S. digital health market expected to grow from $79.10 billion in 2024 to $248.11 billion by 2034, focusing on data analytics, AI, and telehealth to improve efficiency and patient outcomes U.S. Digital Health Market Size to Surpass USD 248.11 Billion by 2034.

Universal Healthcare: Despite Stathis' advocacy, there has been no move towards a national healthcare system. The U.S. still relies on a combination of private insurance and various federal and state programs, with significant disparities in coverage and access Healthcare in the United States. Studies suggest potential benefits, such as saving lives and reducing costs, but no comprehensive system has been implemented Study: More Than 335,000 Lives Could Have Been Saved During Pandemic if U.S. Had Universal Health Care.

Chronic Disease Management: Chronic diseases remain a major focus, with advancements in personalized treatments, AI-driven diagnostics, and preventive care strategies. The chronic disease crisis, as Stathis predicted, continues to drive healthcare costs, with expenditures expected to rise significantly due to an aging population How has U.S. spending on healthcare changed over time?.

Cost-Effectiveness and Efficiency: Stathis' concerns about inefficiencies are echoed in 2025, with experts prioritizing efficiency, productivity, and patient engagement. There's a shift towards non-acute care delivery and specialty pharmacy, aiming to reduce waste, with healthcare prices increasing by 2.3% and utilization by 6.1% in 2023 Top health care trends of 2025 and how they will impact U.S. employers.

Healthcare-Employment Link: Stathis' critique of the employer-based system is relevant, with ongoing outsourcing and wage squeezes due to high healthcare costs. The shift to 401(k) plans and pension freezes, as noted, continues to impact retirement security, aligning with his predictions of economic consequences.

Medicare and Entitlement Crisis: Stathis' warnings about Medicare insolvency are evident, with projections showing deficits and potential bankruptcy by 2047, driven by baby boomer demographics and healthcare inflation, as he detailed.

Comparison with Leading Healthcare Experts

The following experts provide insights that both align with and diverge from Stathis' views:

Marty Makary: As FDA Commissioner in 2025, he emphasizes transparency and efficiency, aligning with Stathis' critiques of the medical-industrial complex. His book Blind Spots (2024) discusses groupthink in medicine, and he advocates for price reform, focusing on reducing waste and improving patient safety TIME100 Health: Marty Makary | TIME.

Uwe Reinhardt: Although deceased, his legacy in health economics continues to influence policy discussions. His book Priced Out (2019) explores the economic costs of healthcare, and his ideas about universal coverage and price transparency resonate with Stathis' views, emphasizing the need for affordability and access Uwe Reinhardt's 'Priced Out' offers lessons in health care costs for all | STAT.

Elizabeth Rosenthal: As editor-in-chief of Kaiser Health News, she focuses on healthcare costs and patient advocacy. Her book An American Sickness (2017) argues that distorted financial incentives are at the root of U.S. healthcare problems, complementing Stathis' concerns about the financial burden on patients and the need for consumer education An American Sickness: How Healthcare Became Big Business and How You Can Take It Back | Amazon.

Atul Gawande: Involved in global health leadership, he emphasizes healthcare delivery systems and teamwork. His work supports the integration of technology in healthcare, aligning with Stathis' vision for telemedicine, and focuses on addressing global health challenges The Pulse of Global Health: Insights from Dr. Atul Gawande, USAID | Meridian International Center.

 

Detailed Comparison and Analysis

To organize the comparison, the following table summarizes the key aspects:

Aspect

Stathis' Research (2006/2009)

Current Developments (2025)

Expert Opinions (2025)

High Healthcare Costs

Criticized U.S. for high costs and poor outcomes; advocated for systemic changes like price controls.

Trump's executive order aims to lower drug prices; Inflation Reduction Act introduces measures, but costs remain high.

Makary: Price transparency; Reinhardt: Cost analysis; Rosenthal: Financial incentives; Gawande: System efficiency.

Lack of Universal Coverage

Advocated for a national system to ensure access.

No move towards universal healthcare; focus on reforms like telehealth expansion.

Reinhardt: Universal coverage need; others focus on access through technology.

Inefficiencies and Waste

Highlighted high administrative costs, fraud, and overuse of services.

Efforts to reduce administrative burdens through AI and digital tools, but inefficiencies persist.

Makary: Reducing waste; Rosenthal: Patient navigation; Gawande: Teamwork for efficiency.

Drug Industry Monopoly

Criticized high drug prices due to lack of controls and industry collusion.

Recent policies aim to address drug prices, but effectiveness is uncertain.

Makary: FDA oversight; Reinhardt: Cost implications; Rosenthal: Industry critique.

Telemedicine and Healthcare IT

Predicted growth as cost-effective solutions for access and efficiency.

Significant market growth; integration of AI and digital health solutions.

Gawande: Technology for care delivery; Makary: Digital tools for transparency.

Chronic Disease Crisis

Emphasized need for better management strategies; chronic diseases drive costs.

Advancements in personalized treatments, AI-driven diagnostics, and preventive care.

Gawande: Prevention focus; Makary: Patient-centered care; Rosenthal: Patient advocacy.

Healthcare-Employment Link

Criticized employer-based system, noting outsourcing impacts.

Ongoing outsourcing and wage squeezes due to high costs, aligning with predictions.

Reinhardt: Economic impacts; Rosenthal: Patient financial burden; Gawande: System reform.

 

Stathis' foresight on telemedicine and healthcare IT is validated by 2025 trends, with significant market growth and technological integration. His concerns about chronic disease management are also still relevant, with ongoing research and advancements in this area. However, his advocacy for systemic changes like universal healthcare and drug price controls is not reflected in the experts' predictions, possibly because these are more political issues than medical or technological ones. The experts are focusing on what they can influence directly through research and innovation, rather than policy changes.

Recent developments, such as Trump's executive order on drug prices and the Inflation Reduction Act, show some progress toward addressing high drug costs, but their long-term impact remains uncertain.

Telemedicine and healthcare IT have indeed grown as Stathis predicted, with AI and digital solutions playing a significant role in improving efficiency and access. However, the lack of progress toward universal healthcare highlights the political challenges of implementing systemic reforms.

 

Conclusion

Mike Stathis' research was prescient in identifying the transformative potential of telemedicine and healthcare IT, which have become central to modern healthcare delivery in 2025.

His concerns about chronic disease management also remain highly relevant, as evidenced by the experts' focus on advancements in this area.

However, his calls for systemic change, such as universal healthcare and drug price controls, have not yet been realized. The 2025 experts are optimistic about innovation but operate within the constraints of the current healthcare framework, focusing on what can be achieved through research and technology rather than advocating for fundamental policy shifts.

Print article

Restrictions Against Reproduction: No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without the prior written permission of the copyright owner and the Publisher.

These articles and commentaries cannot be reposted or used in any publications for which there is any revenue generated directly or indirectly. These articles cannot be used to enhance the viewer appeal of any website, including any ad revenue on the website, other than those sites for which specific written permission has been granted. Any such violations are unlawful and violators will be prosecuted in accordance with these laws.

Article 19 of the United Nations' Universal Declaration of Human Rights: Everyone has the right to freedom of opinion and expression; this right includes freedom to hold opinions without interference and to seek, receive and impart information and ideas through any media and regardless of frontiers.

This publication (written, audio and video) represents the commentary and/or criticisms from Mike Stathis or other individuals affiliated with Mike Stathis or AVA Investment Analytics (referred to hereafter as the “author”). Therefore, the commentary and/or criticisms only serve as an opinion and therefore should not be taken to be factual representations, regardless of what might be stated in these commentaries/criticisms. There is always a possibility that the author has made one or more unintentional errors, misspoke, misinterpreted information, and/or excluded information which might have altered the commentary and/or criticisms. Hence, you are advised to conduct your own independent investigations so that you can form your own conclusions. We encourage the public to contact us if we have made any errors in statements or assumptions. We also encourage the public to contact us if we have left out relevant information which might alter our conclusions. We cannot promise a response, but we will consider all valid information.


0:00
0:00